When combined with eating better and moving more, this can help you lose pounds and decrease your chances of getting cancer, diabetes, or heart problems, especially if youre carrying extra weight
Seven additional Phase 3 trials are expected to report results through 2026
The introduction of glucagon-like peptide-1 receptor agonists (GLP-1RAs) has emerged as a pivotal treatment option for obesity and diabetes, demonstrating efficacy in blood glucose management, weight reduction, cardiovascular disease prevention, and kidney health improvement [10]
Reactive oxygen species and the central nervous system
Individuals may experience significant improvements in immune function, energy levels, and overall health outcomes